SCOPE: To characterize the effects of ingesting the common foodborne mycotoxin deoxynivalenol (DON) on body weight and composition in the high-fat (HF) diet-induced obese mice, a model of human obesity. METHODS AND RESULTS: Female B6C3F1 mice were initially fed HF diets containing 45% kcal (HF45) or 60% kcal (HF60) as fat for 94 days to induce obesity. Half of each group was either continued on unamended HF diets or fed HF diets containing 10 mg/kg DON (DON-HF45 or DON-HF60) for another 54 days. Additional control mice were fed a low-fat (LF) diet containing 10% kcal as fat for the entire 148-day period. DON induced rapid decreases in body weights and fat mass, which stabilized to those of the LF control within 11 days. These effects corresponded closely to a robust transient decrease in food consumption. While lean body mass did not decline in DON-fed groups, further increases were suppressed. DON exposure reduced plasma insulin, leptin, insulin-like growth factor 1, and insulin-like growth factor acid labile subunit as well as increased hypothalamic mRNA level of the orexigenic agouti-related protein. CONCLUSION: DON-mediated effects on body weight, fat mass, food intake, and hormonal levels in obese mice were consistent with a state of chronic energy restriction.
SCOPE: To characterize the effects of ingesting the common foodborne mycotoxin deoxynivalenol (DON) on body weight and composition in the high-fat (HF) diet-induced obesemice, a model of humanobesity. METHODS AND RESULTS: Female B6C3F1 mice were initially fed HF diets containing 45% kcal (HF45) or 60% kcal (HF60) asfat for 94 days to induce obesity. Half of each group was either continued on unamended HF diets or fed HF diets containing 10 mg/kg DON (DON-HF45 or DON-HF60) for another 54 days. Additional control mice were fed a low-fat (LF) diet containing 10% kcal asfat for the entire 148-day period. DON induced rapid decreases in body weights and fat mass, which stabilized to those of the LF control within 11 days. These effects corresponded closely to a robust transient decrease in food consumption. While lean body mass did not decline in DON-fed groups, further increases were suppressed. DON exposure reduced plasma insulin, leptin, insulin-like growth factor 1, and insulin-like growth factor acid labile subunitas well as increased hypothalamic mRNA level of the orexigenic agouti-related protein. CONCLUSION:DON-mediated effects on body weight, fat mass, food intake, and hormonal levels in obesemice were consistent with a state of chronic energy restriction.
Authors: P C Konturek; J W Konturek; M Cześnikiewicz-Guzik; T Brzozowski; E Sito; S J Konturek Journal: J Physiol Pharmacol Date: 2005-12 Impact factor: 3.011
Authors: I Fukuda; M Hotta; N Hizuka; K Takano; Y Ishikawa; K Asakawa-Yasumoto; E Tagami; H Demura Journal: J Clin Endocrinol Metab Date: 1999-06 Impact factor: 5.958
Authors: Lora K Heisler; Erin E Jobst; Gregory M Sutton; Ligang Zhou; Erzsebet Borok; Zoe Thornton-Jones; Hong Yan Liu; Jeffrey M Zigman; Nina Balthasar; Toshiro Kishi; Charlotte E Lee; Carl J Aschkenasi; Chen-Yu Zhang; Jia Yu; Olivier Boss; Kathleen G Mountjoy; Peter G Clifton; Bradford B Lowell; Jeffrey M Friedman; Tamas Horvath; Andrew A Butler; Joel K Elmquist; Michael A Cowley Journal: Neuron Date: 2006-07-20 Impact factor: 17.173
Authors: Jose Cordoba-Chacon; Manuel D Gahete; Ana I Pozo-Salas; Antonio Moreno-Herrera; Justo P Castaño; Rhonda D Kineman; Raúl M Luque Journal: Am J Physiol Endocrinol Metab Date: 2012-08-28 Impact factor: 4.310